propranolol has been researched along with Obesity in 113 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"Anti-obesity effects of calcium antagonists such as benidipine and nifedipine have been described in rodent obesity models, but the mode of action of the calcium antagonists as anti-obesity agents has not been established." | 7.70 | Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium antagonists. ( Bengtsson, T; Cannon, B; Golozoubova, V; Nedergaard, J; Zhao, J, 1999) |
" A reduction of body weight was seen and urinary glucose excretion, increase in body temperature, reduction in maximal plasma glucose and insulin levels in the oral glucose tolerance test, and stimulation of glucose transport into skeletal muscle and adipose tissue, were completely attenuated by the non-specific β-AR antagonist propranolol." | 3.78 | Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). ( Russell, ST; Tisdale, MJ, 2012) |
" This bradycardia was blocked by atropine." | 3.74 | Parasympathetic response to acute stress is attenuated in young Zucker obese rats. ( Brown, DR; El-Wazir, YM; Li, SG; Randall, DC; Silcox, DL; Smith, R, 2008) |
"Anti-obesity effects of calcium antagonists such as benidipine and nifedipine have been described in rodent obesity models, but the mode of action of the calcium antagonists as anti-obesity agents has not been established." | 3.70 | Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium antagonists. ( Bengtsson, T; Cannon, B; Golozoubova, V; Nedergaard, J; Zhao, J, 1999) |
" The metabolic response of lean and obese women to caffeine was studied to see if caffeine could be used to demonstrate the subnormal thermogenesis in obesity previously shown after standard meals or intravenous infusions of noradrenaline." | 3.66 | Caffeine: its effect on catecholamines and metabolism in lean and obese humans. ( Barrand, MA; Callingham, BA; James, WP; Jung, RT; Shetty, PS, 1981) |
"Propranolol is a lipophilic drug so it was predicted that the pharmacokinetics would differ between obese and ideal-weight individuals." | 3.01 | A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine. ( Bertoldi, A; De Rubis, G; Dua, K; El Mekkawi, Z; Ho, A; Kakuzada, L; Mortlock, R; Nesci, I; Pont, L; Smith, V; Williams, K, 2023) |
"The lipophilic beta-adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients." | 2.71 | Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. ( Droździk, M; Gawrońska-Szklarz, B; Jaroszynska, M; Pawlik, A; Sterna, R; Wójcicki, J, 2003) |
"The pharmacokinetic data for the three drugs were qualitatively similar." | 2.68 | Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. ( Carrupt, PA; Cheymol, G; Levron, JC; Poirier, JM; Snoeck, E; Testa, B; Weissenburger, J, 1997) |
" Pharmacokinetic parameters were compared with those obtained previously in non-obese control subjects." | 2.67 | Comparison of propranolol and sotalol pharmacokinetics in obese subjects. ( Barré, J; Cheymol, G; Cohen, A; Hugues, FC; Le Jeunne, C; Poirier, JM, 1990) |
"Propranolol treatment did not modify obesogenic effect of HFD feeding." | 1.46 | Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice. ( Brum, PC; Carneiro, EM; da Silva Franco, N; Davel, AP; Guizoni, DM; Lubaczeuski, C; Santos-Silva, JC; Victorio, JA, 2017) |
" Chronic dosing of propranolol may be required for efficacy; therefore, we tested the efficacy of chronic treatment with either propranolol or phenytoin on RTT mice." | 1.42 | Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs. ( Glaze, DG; Herrera, JA; Kaufmann, WE; Neul, JL; Percy, AK; Pitcher, MR; Skinner, S; Ward, CS; Wehrens, XH, 2015) |
"Obesity is associated with endothelial dysfunction and inflammation." | 1.35 | Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism. ( Fagan, K; Frye, M; McMurtry, I; Orton, EC, 2009) |
" Dose-response curves with epinephrine from lean mice were best fit to a two-component model comprised of 23% high affinity (K(act) = 1." | 1.29 | Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. ( Collins, S; Daniel, KW; Gettys, TW; Ramkumar, V; Rohlfs, EM; Taylor, IL, 1994) |
"Predisposition to obesity has been suggested to be related to a low energy expenditure (EE)." | 1.29 | [Effect of 3-month exercise training on daily energy expenditure in formerly obese women with reduced and stable weight]. ( Astrup, AV; Buemann, B, 1993) |
" Dose-response curves show similar sensitivity, but decreased responsiveness in the lean animal." | 1.28 | Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. ( Bray, GA; Tsujii, S, 1992) |
" In obese subjects the pharmacokinetic data calculated for sotalol (total clearance (CL), volume of distribution (V beta), half-life of elimination (t1/2), were comparable with those measured in the controls." | 1.28 | [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects]. ( Cheymol, G, 1990) |
"Diazepam binding was slightly decreased in the obese as a result of lower serum albumin concentrations and elevated free fatty acids." | 1.27 | Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. ( Benedek, IH; Blouin, RA; McNamara, PJ, 1984) |
" Elimination half-life was similar for the two populations (3." | 1.27 | Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers. ( Barre, J; Cheymol, G; Dry, J; Poirier, JM; Pradalier, A, 1987) |
" After intravenous administration there was no difference in plasma clearance but the volume of distribution was greater (V = 339 l vs 198 l) and the half-life was longer (t1/2 = 5." | 1.27 | A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. ( Bowman, SL; Clements, JA; Hudson, SA; Munro, JF; Simpson, G, 1986) |
"Obesity is a circumstance characterized in the dog fat cell by a modification of the balance between alpha-2 and beta receptors." | 1.26 | Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization. ( Berlan, M; Carpene, C; Dang-Tran, L; Lafontan, M, 1982) |
"Ephedrine is a potential slimming drug that stimulates thermogenesis in man and laboratory animals." | 1.26 | Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors. ( Bukowiecki, L; Follea, N; Jahjah, L, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 62 (54.87) | 18.7374 |
1990's | 22 (19.47) | 18.2507 |
2000's | 13 (11.50) | 29.6817 |
2010's | 14 (12.39) | 24.3611 |
2020's | 2 (1.77) | 2.80 |
Authors | Studies |
---|---|
Xie, F | 1 |
Yang, F | 1 |
Liang, Y | 1 |
Li, L | 1 |
Xia, Y | 1 |
Jiang, F | 1 |
Liu, W | 1 |
Qi, Y | 1 |
Chowdhury, SR | 1 |
Xie, D | 1 |
Fu, L | 1 |
Narayanan, S | 1 |
Wang, S | 1 |
Vasukuttan, V | 1 |
Vyas Devambatla, RK | 1 |
Dai, D | 1 |
Jin, C | 1 |
Snyder, R | 1 |
Laudermilk, L | 1 |
Runyon, SP | 1 |
Maitra, R | 1 |
Mortlock, R | 1 |
Smith, V | 1 |
Nesci, I | 1 |
Bertoldi, A | 1 |
Ho, A | 1 |
El Mekkawi, Z | 1 |
Kakuzada, L | 1 |
Williams, K | 1 |
Pont, L | 1 |
De Rubis, G | 1 |
Dua, K | 1 |
da Silva Franco, N | 1 |
Lubaczeuski, C | 1 |
Guizoni, DM | 1 |
Victorio, JA | 1 |
Santos-Silva, JC | 1 |
Brum, PC | 1 |
Carneiro, EM | 1 |
Davel, AP | 1 |
Baek, K | 2 |
Kang, J | 1 |
Lee, J | 1 |
Kim, M | 1 |
Baek, JH | 2 |
Park, D | 1 |
Hwang, HR | 1 |
Kim, SG | 1 |
Lee, H | 1 |
Matsumura, S | 1 |
Ishikawa, F | 1 |
Sasaki, T | 1 |
Odanaka, M | 1 |
Manio, MCC | 1 |
Fushiki, T | 1 |
Inoue, K | 1 |
Fitzgerald, PJ | 1 |
Molobe, LT | 1 |
Shifa, J | 1 |
Silava, C | 1 |
Mojela, K | 1 |
Cainelli, F | 1 |
Vento, S | 1 |
Herrera, JA | 1 |
Ward, CS | 1 |
Pitcher, MR | 1 |
Percy, AK | 1 |
Skinner, S | 1 |
Kaufmann, WE | 1 |
Glaze, DG | 1 |
Wehrens, XH | 1 |
Neul, JL | 1 |
Diong, C | 1 |
Jones, PP | 1 |
Tsuchimochi, H | 1 |
Gray, EA | 1 |
Hughes, G | 1 |
Inagaki, T | 1 |
Bussey, CT | 1 |
Fujii, Y | 1 |
Umetani, K | 1 |
Shirai, M | 1 |
Schwenke, DO | 1 |
El-Wazir, YM | 1 |
Li, SG | 1 |
Smith, R | 1 |
Silcox, DL | 1 |
Brown, DR | 1 |
Randall, DC | 1 |
Ormsbee, MJ | 1 |
Choi, MD | 1 |
Medlin, JK | 1 |
Geyer, GH | 1 |
Trantham, LH | 1 |
Dubis, GS | 1 |
Hickner, RC | 1 |
Hattori, A | 1 |
Mawatari, K | 1 |
Tsuzuki, S | 1 |
Yoshioka, E | 1 |
Toda, S | 1 |
Yoshida, M | 1 |
Yasui, S | 1 |
Furukawa, H | 1 |
Morishima, M | 1 |
Ono, K | 1 |
Ohnishi, T | 1 |
Nakano, M | 1 |
Harada, N | 1 |
Takahashi, A | 1 |
Nakaya, Y | 1 |
Belza, A | 1 |
Gille, MB | 1 |
Schultz John, S | 1 |
Kondrup, J | 1 |
Frye, M | 1 |
McMurtry, I | 1 |
Orton, EC | 1 |
Fagan, K | 1 |
An, S | 1 |
Han, JI | 1 |
Kim, MJ | 1 |
Park, JS | 1 |
Han, JM | 1 |
Baek, NI | 1 |
Chung, HG | 1 |
Choi, MS | 1 |
Lee, KT | 1 |
Jeong, TS | 1 |
Russell, ST | 2 |
Tisdale, MJ | 2 |
Mirbolooki, MR | 1 |
Constantinescu, CC | 1 |
Pan, ML | 1 |
Mukherjee, J | 1 |
Wójcicki, J | 1 |
Jaroszynska, M | 1 |
Droździk, M | 1 |
Pawlik, A | 1 |
Gawrońska-Szklarz, B | 1 |
Sterna, R | 1 |
Lennon, JA | 1 |
Brech, WJ | 1 |
Gordon, ES | 1 |
Jung, RT | 3 |
Shetty, PS | 3 |
James, WP | 4 |
Arch, JR | 2 |
Ainsworth, AT | 1 |
Berlan, M | 4 |
Dang-Tran, L | 2 |
Lafontan, M | 5 |
Denard, Y | 1 |
Stein, PM | 1 |
Hassanein, RS | 1 |
Lukert, BP | 1 |
Carpene, C | 2 |
Bukowiecki, L | 1 |
Jahjah, L | 1 |
Follea, N | 1 |
Yen, TT | 1 |
McKee, MM | 1 |
Stamm, NB | 1 |
Bemis, KG | 1 |
Wilson, S | 1 |
Thurlby, PL | 1 |
Benedek, IH | 2 |
Blouin, RA | 2 |
McNamara, PJ | 2 |
Inoue, S | 1 |
Mullen, YS | 1 |
Bray, GA | 3 |
Rothwell, NJ | 3 |
Stock, MJ | 3 |
Fiske, WD | 1 |
Griffen, WO | 1 |
Bell, RM | 1 |
Hervey, GR | 1 |
Tobin, G | 1 |
Lieberman, E | 1 |
Dieterlen, P | 1 |
Desjeux, JF | 1 |
Giraud, M | 1 |
Villard, S | 1 |
Lestradet, H | 1 |
Barrand, MA | 1 |
Callingham, BA | 1 |
Atkinson, RL | 1 |
Dahms, WT | 1 |
Sperling, MA | 1 |
Ahrén, B | 1 |
Lundquist, I | 1 |
Saville, ME | 1 |
McCrory, WW | 1 |
Uza, G | 1 |
Pavel, O | 1 |
Uza, D | 1 |
Vlaicu, R | 1 |
Yoshida, T | 1 |
Sakane, N | 1 |
Wakabayashi, Y | 1 |
Yoshioka, K | 1 |
Umekawa, T | 1 |
Kondo, M | 1 |
Bégin-Heick, N | 2 |
Van Vliet, BN | 2 |
Hall, JE | 1 |
Mizelle, HL | 1 |
Montani, JP | 2 |
Smith, MJ | 1 |
Collins, S | 1 |
Daniel, KW | 1 |
Rohlfs, EM | 1 |
Ramkumar, V | 1 |
Taylor, IL | 1 |
Gettys, TW | 1 |
Buemann, B | 2 |
Astrup, AV | 1 |
Piccirillo, G | 1 |
Vetta, F | 1 |
Fimognari, FL | 1 |
Ronzoni, S | 1 |
Lama, J | 1 |
Cacciafesta, M | 1 |
Marigliano, V | 1 |
Kuo, CH | 1 |
Ding, Z | 1 |
Ivy, JL | 1 |
Cheymol, G | 4 |
Poirier, JM | 3 |
Carrupt, PA | 1 |
Testa, B | 1 |
Weissenburger, J | 1 |
Levron, JC | 1 |
Snoeck, E | 1 |
Zhao, J | 1 |
Golozoubova, V | 1 |
Bengtsson, T | 1 |
Cannon, B | 1 |
Nedergaard, J | 1 |
Paolisso, G | 1 |
Manzella, D | 1 |
Tagliamonte, MR | 1 |
Rizzo, MR | 1 |
Gambardella, A | 1 |
Varricchio, M | 1 |
Flechtner-Mors, M | 1 |
Ditschuneit, HH | 1 |
Yip, I | 1 |
Adler, G | 1 |
Berger, JJ | 1 |
Barnard, RJ | 1 |
Antic, V | 1 |
Kiener-Belforti, F | 1 |
Tempini, A | 1 |
Børsheim, E | 1 |
Lönnroth, P | 1 |
Knardahl, S | 1 |
Jansson, PA | 1 |
Getty, L | 1 |
Panteleon, AE | 1 |
Mittelman, SD | 1 |
Dea, MK | 1 |
Bergman, RN | 1 |
Picard, F | 1 |
Richard, D | 1 |
Timofeeva, E | 1 |
Deshaies, Y | 1 |
Seematter, G | 1 |
Guenat, E | 1 |
Schneiter, P | 1 |
Cayeux, C | 1 |
Jéquier, E | 1 |
Tappy, L | 1 |
van Aggel-Leijssen, DP | 1 |
Saris, WH | 1 |
Hul, GB | 1 |
van Baak, MA | 1 |
Galitzky, J | 2 |
Sengenès, C | 1 |
Thalamas, C | 1 |
Marques, MA | 1 |
Senard, JM | 1 |
Stepp, DW | 1 |
Frisbee, JC | 1 |
Saitta, A | 1 |
Quartarone, M | 1 |
Cucinotta, D | 1 |
Mangano, C | 1 |
Pizzoleo, MA | 1 |
Squadrito, G | 2 |
Burns, TW | 2 |
Terry, BE | 2 |
Langley, PE | 2 |
Robison, GA | 2 |
Boyer, PA | 1 |
O'rourke, RA | 1 |
Schnitzler, RN | 1 |
Barbarine, A | 1 |
De Marinis, L | 1 |
Troncone, L | 1 |
Bernasconi, S | 1 |
Giovannelli, G | 1 |
Andler, W | 1 |
Olefsky, J | 2 |
Crapo, PA | 1 |
Ginsberg, H | 1 |
Reaven, GM | 2 |
Hickler, RB | 1 |
Cabezas-Cerrato, J | 1 |
Mur, AL | 1 |
Aranguren, LV | 1 |
Vila, T | 1 |
Fernández-Cruz, A | 1 |
Cugini, P | 1 |
Giovannini, C | 1 |
Rossi, G | 1 |
Sellini, M | 1 |
Sartori, MP | 1 |
Tsujii, S | 1 |
Astrup, A | 1 |
Madsen, J | 1 |
Christensen, NJ | 1 |
Saad, MF | 1 |
Alger, SA | 1 |
Zurlo, F | 1 |
Young, JB | 1 |
Bogardus, C | 2 |
Ravussin, E | 2 |
Le Feuvre, RA | 1 |
Woods, AJ | 1 |
Riviere, D | 1 |
Foureau, M | 1 |
Tran, MA | 1 |
Flores, R | 1 |
Louvet, JP | 1 |
Houin, G | 1 |
Le Jeunne, C | 1 |
Cohen, A | 1 |
Barré, J | 2 |
Hugues, FC | 1 |
Bürgi, U | 1 |
Bürgi-Saville, ME | 1 |
Burgherr, J | 1 |
Clément, M | 1 |
Lauber, K | 1 |
Skołuda, A | 1 |
Kozłowska, F | 1 |
Paradowski, S | 1 |
Gracz, M | 1 |
Rebourcet, MC | 1 |
Guichard, C | 1 |
Lavau, M | 1 |
York, DA | 3 |
Holt, SJ | 3 |
Marchington, D | 2 |
Welsh, J | 1 |
Pradalier, A | 1 |
Dry, J | 1 |
Grzywa, M | 1 |
Wheal, HV | 1 |
Bowman, SL | 1 |
Hudson, SA | 1 |
Simpson, G | 1 |
Munro, JF | 1 |
Clements, JA | 1 |
Zed, C | 1 |
Simon, J | 1 |
Leclercq, B | 1 |
Schwartz, RS | 1 |
Robbins, DC | 1 |
Wolfe, RR | 1 |
Horton, ES | 1 |
Danforth, E | 1 |
Sims, EA | 1 |
Allars, J | 1 |
Lotti, G | 1 |
Delitala, G | 1 |
Masala, A | 1 |
Tempero, KF | 1 |
Olefsky, JM | 1 |
Farquhar, JW | 2 |
Atkins, T | 1 |
Matty, AJ | 1 |
Tulloch, BR | 1 |
Vydelingum, N | 1 |
Galton, DJ | 1 |
Laube, H | 1 |
Fussgänger, RD | 1 |
Pfeiffer, EF | 1 |
Robertson, RP | 1 |
Porte, D | 1 |
Reaven, G | 1 |
Carducci Artenisio, A | 1 |
Sprovieri, M | 1 |
Albanese, MC | 1 |
Allegra, V | 1 |
Ragonese, F | 1 |
Corsi, V | 1 |
Rath, R | 1 |
Kujalová, V | 1 |
Veselková, A | 1 |
Balestreri, R | 1 |
Bertolini, S | 1 |
Elicio, N | 1 |
Vandeweghe, M | 1 |
Vermeulen, A | 1 |
Cranston, WI | 1 |
Parra, A | 1 |
Schultz, RB | 1 |
Kato, Y | 1 |
Morimoto, M | 1 |
Imura, H | 1 |
Herrold, JN | 1 |
Tzagournis, M | 1 |
Hammerl, H | 1 |
Kränzl, C | 1 |
Köhn, H | 1 |
Nebosis, G | 1 |
Pichler, O | 1 |
Studlar, M | 1 |
Kühns, K | 1 |
Wettich, JE | 1 |
Samwer, KF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women[NCT05351476] | 120 participants (Anticipated) | Interventional | 2022-05-20 | Recruiting | |||
Phase I, Open-Label Study to Evaluate Potential Pharmacokinetic of Orally Administered Oseltamivir in Healthy Obese Thai Adult Subjects[NCT01049763] | Phase 1 | 24 participants (Actual) | Interventional | 2010-01-31 | Completed | ||
Influence of Walking on Spontaneous Physical Activity and on Lipid Oxidation Following Dietary Treatment of Obesity[NCT00775970] | 20 participants (Anticipated) | Interventional | 2008-05-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for propranolol and Obesity
Article | Year |
---|---|
A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine.
Topics: Half-Life; Humans; Kinetics; Obesity; Precision Medicine; Propranolol | 2023 |
The part played by variation of energy expenditure in the regulation of energy balance.
Topics: Animals; Body Composition; Body Weight; Calorimetry, Indirect; Diet; Dietary Fats; Energy Intake; En | 1982 |
Blood pressure and primary hypertension in childhood and adolescence.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure Determination; Cardiovascular Diseases; C | 1980 |
Angina pectoris: diagnosis, evaluation and therapy.
Topics: Angina Pectoris; Angiography; Digitalis Glycosides; Ethanol; Female; Heart Function Tests; Humans; M | 1973 |
Advances in medicine.
Topics: Acute Kidney Injury; Asthma; Blindness; Catecholamines; Contraceptives, Oral; Coronary Disease; Guan | 1968 |
10 trials available for propranolol and Obesity
Article | Year |
---|---|
The beta-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients.
Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Blood Pressure; Caffeine; Capsaicin; Catechin; | 2009 |
Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Area Under Curve; Atenolol; Blood Pressure | 2003 |
The effect of beta-adrenergic blockade on metabolic rate and peripheral thyroid metabolism in obesity.
Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Catecholamines; Diet, Reducing; Female; Humans | 1980 |
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Adult; Area Under Curve; Benzopyrans; Binding Sites; Bi | 1997 |
Sympathetic modulation of lipolysis in subcutaneous adipose tissue: effects of gender and energy restriction.
Topics: Abdomen; Adipose Tissue; Adrenergic Agents; Adult; Energy Intake; Epinephrine; Female; Glycerol; Hum | 1999 |
Effects of mental stress on insulin-mediated glucose metabolism and energy expenditure in lean and obese women.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Energy Metabolism; Epinephrine; | 2000 |
Short-term effects of weight loss with or without low-intensity exercise training on fat metabolism in obese men.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Diet, Reducing; Energy Intake; Exercise; F | 2001 |
A 24-h energy expenditure study on reduced-obese and nonobese women: effect of beta-blockade.
Topics: Adult; Blood Glucose; Body Composition; Body Mass Index; Carbohydrate Metabolism; Energy Metabolism; | 1992 |
Comparison of propranolol and sotalol pharmacokinetics in obese subjects.
Topics: Adult; Blood Pressure; Cardiac Output; Chromatography, High Pressure Liquid; Creatinine; Female; Hea | 1990 |
Metabolic response to simultaneous infusion of epinephrine and propranolol in obese adolescents.
Topics: Adolescent; Blood Glucose; Clinical Trials as Topic; Drug Synergism; Epinephrine; Fatty Acids, Nones | 1969 |
98 other studies available for propranolol and Obesity
Article | Year |
---|---|
Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors.
Topics: Animals; Antigens, CD; Cell Membrane Permeability; Diabetes Mellitus, Type 2; Esters; Glucose; Human | 2019 |
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice.
Topics: Animals; Apelin Receptors; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Pyra | 2021 |
Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Diet, High-Fat; Endot | 2017 |
The Time Point-Specific Effect of Beta-Adrenergic Blockade in Attenuating High Fat Diet-Induced Obesity and Bone Loss.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Meta | 2018 |
Blocking β₁/β₂-Adrenergic Signaling Reduces Dietary Fat Absorption by Suppressing Expression of Pancreatic Lipase in High Fat-Fed Mice.
Topics: Acinar Cells; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic AMP Response Element-Binding | 2018 |
Voluntary Corn Oil Ingestion Increases Energy Expenditure and Interscapular UCP1 Expression Through the Sympathetic Nerve in C57BL/6 Mice.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Corn Oil; Energy Intake; Energy Metabol | 2018 |
Is elevated norepinephrine an etiological factor in some cases of Parkinson's disease?
Topics: Animals; Antidepressive Agents; Bipolar Disorder; Disease Progression; Humans; Mice; Models, Theoret | 2014 |
Primary pseudotumor cerebri syndrome in a young obese African woman.
Topics: Acetazolamide; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antihypertensive Agents; Diuretic | 2014 |
Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.
Topics: Adrenergic beta-Antagonists; Animals; Anticonvulsants; Arrhythmias, Cardiac; Disease Models, Animal; | 2015 |
Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the 'obesity paradox'.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Lung | 2016 |
Parasympathetic response to acute stress is attenuated in young Zucker obese rats.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Blood Pressure; Body Weight; Bradycardia; Conditioni | 2008 |
Regulation of fat metabolism during resistance exercise in sedentary lean and obese men.
Topics: Adipose Tissue; Adult; Body Mass Index; Energy Metabolism; Exercise; Exercise Test; Glycerol; Humans | 2009 |
Beta-adrenergic-AMPK pathway phosphorylates acetyl-CoA carboxylase in a high-epinephrine rat model, SPORTS.
Topics: Acetyl-CoA Carboxylase; Adrenergic beta-Antagonists; AMP-Activated Protein Kinases; Analysis of Vari | 2010 |
Use of fat-fed rats to study the metabolic and vascular sequelae of obesity and beta-adrenergic antagonism.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Body Weight; Cytokines; Di | 2009 |
Ethanolic extracts of Brassica campestris spp. rapa roots prevent high-fat diet-induced obesity via beta(3)-adrenergic regulation of white adipocyte lipolytic activity.
Topics: Adipocytes, White; Adrenergic Agents; Animals; Anti-Obesity Agents; Brassica; Cyclic AMP-Dependent P | 2010 |
Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG).
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Blood Glucose; Blotting, Western; Body Weight; | 2012 |
Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG).
Topics: Adipocytes; Administration, Oral; Adrenergic beta-Antagonists; Animals; Body Temperature; Body Weigh | 2012 |
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxeti | 2013 |
Effect of a short period of cold exposure on plasma FFA level in lean and obese humans.
Topics: Blood Glucose; Cold Temperature; Fasting; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; M | 1967 |
Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats.
Topics: Adrenergic beta-Agonists; Animals; Body Composition; Body Temperature Regulation; Body Weight; Energ | 1983 |
Influence of hypocaloric diet on alpha-adrenergic responsiveness of obese human subcutaneous adipocytes.
Topics: Adipose Tissue; Adolescent; Adult; Diet, Reducing; Energy Intake; Epinephrine; Female; Glucose Toler | 1981 |
Predicting weight loss success among obese clients in a hospital nutrition clinic.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care Facilities; Body Weight; Estrogens, Conjugated | 1981 |
Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
Topics: Adipose Tissue; Animals; Clonidine; Dogs; Epinephrine; Isoproterenol; Lipolysis; Obesity; Prazosin; | 1982 |
Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Cells, Cultured; Dose-Response Relation | 1982 |
Stimulation of cyclic AMP and lipolysis in adipose tissue of normal and obese Avy/a mice by LY79771, a phenethanolamine, and stereoisomers.
Topics: 2-Hydroxyphenethylamine; Adipose Tissue; Animals; Cyclic AMP; Fatty Acids, Nonesterified; Lipolysis; | 1983 |
Genetically obese C57BL/6 ob/ob mice respond normally to sympathomimetic compounds.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Energy Metabolism; Ephedrine; Ethanolam | 1984 |
Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.
Topics: Adolescent; Adult; Blood Proteins; Diazepam; Humans; Lipids; Lipoproteins; Male; Obesity; Orosomucoi | 1984 |
Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose.
Topics: Animals; Atropine; Epinephrine; Female; Glucose; Hyperinsulinism; Isoproterenol; Obesity; Phentolami | 1983 |
Acute effects of fat and carbohydrate on metabolic rate in normal, cold-acclimated and lean and obese (fa/fa) Zucker rats.
Topics: Acclimatization; Adipose Tissue, Brown; Animals; Atropine; Body Temperature Regulation; Cold Tempera | 1983 |
Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.
Topics: Adult; Blood Proteins; Diazepam; Female; Humans; Obesity; Orosomucoid; Propranolol; Protein Binding | 1983 |
[Measurement of insulin sensitivity in obese or diabetic children in vivo. A comparison of three methods (author's transl)].
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Epinephrine; Glucose; Humans; Insuli | 1980 |
Caffeine: its effect on catecholamines and metabolism in lean and obese humans.
Topics: Adult; Blood Glucose; Body Temperature Regulation; Caffeine; Catecholamines; Fatty Acids, Nonesterif | 1981 |
Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
Topics: Adult; Blood Glucose; Epinephrine; Glucagon; Humans; Insulin; Insulin Secretion; Obesity; Phentolami | 1981 |
Modulation of basal insulin secretion in the obese, hyperglycemic mouse.
Topics: Animals; Atropine Derivatives; Blood Glucose; Insulin; Mannoheptulose; Mice; Mice, Obese; Obesity; P | 1982 |
Factors influencing the acute effect of food on oxygen consumption in the rat.
Topics: Adaptation, Physiological; Animals; Cold Temperature; Eating; Energy Metabolism; Feeding Behavior; M | 1982 |
Essential hypertension in childhood.
Topics: Adolescent; Child; Diet, Sodium-Restricted; Electrocardiography; Humans; Hydrochlorothiazide; Hypert | 1982 |
Effect of propranolol on hypophosphatemia in overweight.
Topics: Adult; Blood Pressure; Electrolytes; Female; Humans; Male; Middle Aged; Obesity; Phosphates; Propran | 1982 |
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese mice.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; An | 1994 |
Beta 3-adrenergic activation of adenylyl cyclase in mouse white adipocytes: modulation by GTP and effect of obesity.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Al | 1995 |
Reduced parasympathetic control of heart rate in obese dogs.
Topics: Animals; Atropine; Baroreflex; Cardiovascular System; Dogs; Heart Rate; Hemodynamics; Hexamethonium; | 1995 |
Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
Topics: Adenylyl Cyclases; Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adrenergic beta- | 1994 |
[Effect of 3-month exercise training on daily energy expenditure in formerly obese women with reduced and stable weight].
Topics: Adrenergic beta-Antagonists; Adult; Body Weight; Energy Metabolism; Exercise; Female; Humans; Obesit | 1993 |
Power spectral analysis of heart rate variability in obese subjects: evidence of decreased cardiac sympathetic responsiveness.
Topics: Adrenergic beta-Antagonists; Adult; Body Mass Index; Female; Heart; Heart Rate; Humans; Male; Middle | 1996 |
Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; C | 1996 |
Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium antagonists.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Body Temperature Regulation; Calcium Ch | 1999 |
Effects of different insulin infusion rates on heart rate variability in lean and obese subjects.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Calorimetry, Ind | 1999 |
Effect of diet on fat cell size and hormone-sensitive lipase activity.
Topics: Adipocytes; Animals; Cell Size; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Sucrose; Fatty Ac | 1999 |
Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Pressure D | 2000 |
No difference in the lipolytic response to beta-adrenoceptor stimulation in situ but a delayed increase in adipose tissue blood flow in moderately obese compared with lean men in the postexercise period.
Topics: Adipose Tissue; Adult; Exercise; Fatty Acids, Nonesterified; Glycerol; Heart Rate; Humans; Hydralazi | 2000 |
Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.
Topics: Activity Cycles; Adrenergic beta-Antagonists; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dog | 2000 |
Abnormal insulin and beta-adrenergic modulation of lipoprotein liipase during refeeding after prolonged fasting in the Zucker rat.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Fasting; Food Deprivation | 2000 |
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men.
Topics: Adipocytes; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atrial Natriuretic Factor; Bio | 2001 |
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart | 2002 |
[Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation].
Topics: Adrenergic beta-Antagonists; Blood Glucose; Diabetes Mellitus; Glucose; Humans; Insulin; Insulin Sec | 1979 |
In-vitro observations on isolated adipose tissue cells from hyperobese subjects.
Topics: Adipose Tissue; Adult; Cyclic AMP; Epinephrine; Female; Glycerol; Humans; Insulin; Lipid Metabolism; | 1977 |
The effect of fasting on the adrenergic receptor activity of human adipocytes.
Topics: Adipose Tissue; Cyclic AMP; Epinephrine; Fasting; Humans; In Vitro Techniques; Lipid Metabolism; Obe | 1979 |
Angina pectoris: an overview.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Blood Pressure; Coronary Art | 1977 |
[Some aspects of the dynamic behavior of IRI in obesity and in diabetes mellitus].
Topics: Adult; Aged; Aminophylline; Antigens; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucose; G | 1979 |
The effects of beta adrenergic blockade on basal metabolism and peripheral thyroid metabolism.
Topics: Adult; Basal Metabolism; Energy Intake; Humans; Middle Aged; Obesity; Propranolol; Thyroid Gland; Th | 1979 |
Growth hormone response to propranolol and L--dopa in obese subjects.
Topics: Adolescent; Adult; Female; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Obesity; P | 1978 |
[Somatotropic response to a propranolol-glucagon test].
Topics: Child; Glucagon; Growth Disorders; Growth Hormone; Humans; Hypothyroidism; Obesity; Pituitary Gland; | 1976 |
Metabolic effects of increased caloric intake in man.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Diet; Eating; Epinephrine; Fasting; Female; Glucose; | 1975 |
The office management of hypertension.
Topics: Adult; Age Factors; Ambulatory Care; Antihypertensive Agents; Benzothiadiazines; Black or African Am | 1975 |
[Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
Topics: Administration, Oral; Adult; Aged; Female; Growth Hormone; Humans; Injections, Intravenous; Levodopa | 1975 |
[Influence of propranolol on daily variations in blood cortisol in essential obestiy].
Topics: Adolescent; Adrenal Cortex; Adrenal Glands; Adult; Circadian Rhythm; Female; Humans; Hydrocortisone; | 1975 |
Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Clonidine; Dose-Response Relationship, Drug; Drug Inte | 1992 |
Ethnic differences in sympathetic nervous system-mediated energy expenditure.
Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Energy Metabolism; Fasting; Humans; Indians, N | 1991 |
Effects of central injection of glucose on thermogenesis in normal, VMH-lesioned and genetically obese rats.
Topics: Animals; Blood Glucose; Body Temperature Regulation; Dose-Response Relationship, Drug; Glucose; Inje | 1991 |
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Catecholamines; Epinephrine; Fatty Acids | 1991 |
[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Female; Humans; Male; Obesity; Propanolamines; Propr | 1990 |
T3 plus high doses of beta-blockers: effects on energy intake, body composition, bat and heart in rats.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Atenolol; Body Composit | 1990 |
[Selected hemodynamic parameters in overweight patients with mild and moderate hypertension treated with low caloric diet].
Topics: Adult; Diet, Reducing; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Obesity; Propr | 1991 |
Increased alpha 2-adrenergic binding sites and antilipolytic effect in adipocytes from genetically obese rats.
Topics: Adipose Tissue; Animals; Binding Sites; Brimonidine Tartrate; Dioxanes; Epinephrine; Idazoxan; Kinet | 1990 |
Regulation of brown adipose tissue thermogenesis by corticosterone in obese fa/fa rats.
Topics: Adipose Tissue, Brown; Adrenalectomy; Aldosterone; Animals; Body Temperature Regulation; Body Weight | 1985 |
The regulation of adenylate cyclase in liver membranes of lean and obese mice.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cell Membrane; Cholera Toxin; Enzyme Activation | 1988 |
Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
Topics: Adult; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Obesity; Propranolol | 1987 |
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; P | 1986 |
Hypothalamic control of brown adipose tissue in Zucker lean and obese rats. Effect of electrical stimulation of the ventromedial nucleus and other hypothalamic centres.
Topics: Adipose Tissue, Brown; Animals; Body Temperature; Efferent Pathways; Electric Stimulation; Female; H | 1987 |
A comparison of the pharmacokinetics of propranolol in obese and normal volunteers.
Topics: Administration, Oral; Adult; Biological Availability; Body Weight; Female; Half-Life; Humans; Infusi | 1986 |
Dietary thermogenesis in obesity. Response to carbohydrate and protein meals: the effect of beta-adrenergic blockade and semistarvation.
Topics: Calorimetry; Dietary Carbohydrates; Dietary Proteins; Energy Intake; Energy Metabolism; Female; Huma | 1986 |
Fat and lean chickens: prefattening period and in vivo sensitivity to insulin, atropine, and propranolol.
Topics: Adipose Tissue; Animals; Atropine; Blood Glucose; Body Weight; Chickens; Diet; Fasting; Food; Glucos | 1985 |
Glucose-induced thermogenesis and insulin resistance in man.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Body Weight; Diabetes Mellitus; Diabetes Melli | 1985 |
Regulation of sympathetic activity in lean and obese Zucker (fa/fa) rats.
Topics: Acclimatization; Adipose Tissue, Brown; Adrenalectomy; Animals; Body Temperature Regulation; Cold Te | 1985 |
Letter: Enhancement of levodopa-induced growth-hormone stimulation by practolol.
Topics: Drug Synergism; Growth Hormone; Humans; Levodopa; Obesity; Practolol; Propranolol; Stimulation, Chem | 1974 |
Reappraisal of the role of insulin in hypertriglyceridemia.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Diet; Epinephrine; Female; Glucose; Glucose Tolera | 1974 |
[Six years' experience with a musculoplastic technic].
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists | 1971 |
Cyclic adenosine monophosphate in human adipose tissue.
Topics: Acetanilides; Adenylyl Cyclases; Adipose Tissue; Adrenal Glands; Adrenergic beta-Antagonists; Amino | 1972 |
The effect of a -adrenergic blocker on insulin release from the isolated perfused pancreas of obese mice.
Topics: Animals; Depression, Chemical; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of L | 1972 |
The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor.
Topics: Blood Glucose; Diabetes Mellitus; Glucose; Humans; Insulin; Isoproterenol; Obesity; Propranolol; Rec | 1973 |
Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Epinephrine; Female; Glucose; Glucose Tolerance Test; Human | 1973 |
Effects of propranolol on HGH secretion after endovenous tolbutamide load in obese subjects.
Topics: Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Growth Hormone; Humans; Middle Aged; Obesity | 1973 |
Catecholamines and obesity, fasting and the adrenergic system.
Topics: Blood Glucose; Catecholamines; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Humans; Ket | 1973 |
[Effect of propranolol on the function of the hypothalamo-pituitary-adrenal system in normal and obese subjects during insulin test of hypoglycemia].
Topics: Adolescent; Adult; Blood Glucose; Female; Humans; Hypothalamo-Hypophyseal System; Insulin; Male; Mid | 1973 |
Growth hormone and cortisol secretion after propranolol--glucagon testing in the adult.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Glucose; Female; Glucagon; Growth Hormone; Huma | 1974 |
Plasma growth hormone in hyperthyroidism and obesity: effect of propranolol infusion.
Topics: Blood Glucose; Fatty Acids, Nonesterified; Growth Hormone; Humans; Hyperthyroidism; Obesity; Propran | 1970 |
The role of starvation, hypoglycemia, and adrenergic blockade on growth hormone secretion in obesity.
Topics: Adult; Catecholamines; Fasting; Female; Growth Hormone; Humans; Hypoglycemia; Injections, Intravenou | 1970 |
[The effects of appetitie depressants on fat and carbohydrate metabolism].
Topics: Acetates; Appetite Depressants; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Germany, | 1971 |
[Risk factors, prognosis, treatment and rehabilitation in myocardial infarct].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Anticoagulants; Cholesterol; Female; Humans; Hypertension | 1967 |